Antares Pharma to Present at the Jefferies 2012 Global Healthcare Conference

  Antares Pharma to Present at the Jefferies 2012 Global Healthcare Conference

Jefferies Global Healthcare Conference London 2012

Business Wire

EWING, N.J. -- November 08, 2012

Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Paul K. Wotton,
Ph.D., President and Chief Executive Officer, will present at the Jefferies
2012 Global Healthcare Conference on Thursday November 15, 2012 at 10:40 am
(GMT) / 5:40 am (EST) in London.

A live webcast of the presentation will be available via the “Investor
Relations” page of the Antares website, www.antarespharma.com. A replay of the
webcast will also be archived on Antares’ website for 90 days following the
presentation.

About Antares Pharma

Antares Pharma focuses on self-administered parenteral pharmaceutical products
and topical gel-based medicines. The Company's technology platforms include
VIBEX™ disposable Medi-Jet, disposable multi-use pen injectors and Vision™
reusable needle-free injectors marketed as Tjet^® and Zomajet^® by Teva
Pharmaceutical Industries, Ltd (Teva) and Ferring Pharmaceuticals (Ferring),
respectively. Antares Pharma has a multi-product deal with Teva that includes
Tev-Tropin^® human growth hormone (hGH), VIBEX epinephrine and several other
products. Antares Pharma’s partnership with Ferring includes Zomacton^® hGH.
In the U.S. Antares has received FDA approval for Gelnique 3%™, a treatment
for overactive bladder that is marketed by Watson Pharmaceuticals, Inc.
Elestrin^® (estradiol gel) is FDA approved for the treatment of
moderate-to-severe vasomotor symptoms associated with menopause, and is
marketed in the U.S. by Meda Pharma. Antares Pharma has two facilities in the
U.S. The Parenteral Products Group located in Minneapolis, Minnesota directs
the manufacturing and marketing of the Company’s reusable needle-free
injection devices and related disposables, and develops its disposable
pressure-assisted VIBEX Medi-Jet and pen injector systems. The Company’s
corporate head office and Product Development Group are located in Ewing, New
Jersey.

Contact:

Antares Pharma, Inc.
Jack Howarth
Vice President, Corporate Affairs
609-359-3016
jhowarth@antarespharma.com
 
Press spacebar to pause and continue. Press esc to stop.